Asylia Therapeutics, Inc.
Biotechnology company · Houston, Texas, United States
Asylia Therapeutics, Inc. is a biotechnology company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2019. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $246,451 in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $8.2 million sold in a notice filed in 2021.
Asylia Therapeutics at a glance
What does Asylia Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $246,451 in total (2022). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $8.2 million sold (2021).
Frequently asked questions about Asylia Therapeutics
Where is Asylia Therapeutics headquartered?
Asylia Therapeutics, Inc. is headquartered in Houston, Texas, United States.
What does Asylia Therapeutics do?
Asylia Therapeutics, Inc. is a biotechnology company.
When was Asylia Therapeutics founded?
The earliest incorporation on record for Asylia Therapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- Pulmotect, Inc.Houston, Texas, United States
- Kiromic Biopharma, Inc.Houston, Texas, United States
- March Biosciences, Inc.Houston, Texas, United States
- Autoimmunity Biologic Solutions Inc.Houston, Texas, United States
- Fannin Partners, LLCHouston, Texas, United States
- Brevitest Technologies, Inc.Houston, Texas, United States
- Pupil Bio, Inc.Houston, Texas, United States
- Procyrion, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences